Molecular Imaging of Epidermal Growth Factor Receptor in Colorectal Neoplasia Using Confocal Laser Endomicroscopy
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The study aims to:
- Achieve molecular imaging of EGFR in patients with colorectal neoplasia in vivo using confocal laser endomicroscopy.
- Compare the results of in vivo EGFR-specific molecular imaging with CLE and ex vivo immunohistochemistry .
| Condition |
|---|
|
Colorectal Cancer Colorectal Adenoma |
| Study Type: | Observational |
| Study Design: | Time Perspective: Prospective |
| Official Title: | In Vivo Molecular Imaging of Epidermal Growth Factor Receptor in Patients With Colorectal Neoplasia Using Confocal Laser Endomicroscopy |
Take biospecimen during colonoscopy.
| Enrollment: | 40 |
| Study Start Date: | January 2011 |
| Study Completion Date: | July 2011 |
| Primary Completion Date: | July 2011 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
colorectal cancer
Patients with colorectal carcinoma during conventional endoscopic imaging.
|
|
colorectal adenoma
Patients with colorectal adenoma during conventional endoscopic imaging.
|
Detailed Description:
Various kinds of tumor markers have been shown to be over-expressed in colorectal cancer, including epidermal growth factor receptor(EGFR). The conventional detection method of EGFR expression in colorectal neoplasia is immunohistochemistry which is time-consuming, and the immunoreactivity can be affected by storage and fixation of tissues. Confocal laser endomicrosopy is a newly developed device which could identify the cellular and subcellular structures clearly with the magnification at×1000, making it possible to explore the physiological and pathological molecular mechanism of the gastrointestinal tract. So the study aims to achieve molecular imaging of EGFR in colorectal neoplasia in vivo using confocal laser endomicroscopy.
Eligibility| Ages Eligible for Study: | 18 Years to 80 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
patients known to have large polypoid lesions in colon or rectum from previous examinations from outpatients and inpatients at Qilu Hospital were enrolled into the study
Inclusion Criteria:
●Patients known to have large polypoid lesions in colon or rectum from previous examinations from outpatients and inpatients at Qilu Hospital were enrolled into the study
Exclusion Criteria:
- Patients who are allergic to fluorescein sodium
- Patients with impaired cardiac, liver or renal function
- Patients who are unwilling to sign or give the informed consent form
- Patients with giant tumors or obvious GI tract bleeding which make it hard or impossible to observe the lesions
- Patients with coagulopathy
- Patients with pregnancy or breastfeeding
Contacts and Locations| China, Shandong | |
| Department of Gastroenterology, Qilu Hospital, Shandong University | |
| Jinan, Shandong, China | |
| Study Director: | Yanqing Li, PhD. MD. | Department of Gastroenterology, Qilu Hospital |
More Information
No publications provided
| Responsible Party: | Yanqing Li, Chief of the Department of Gastroenterology, Qilu Hospital, Shandong University, Shandong University |
| ClinicalTrials.gov Identifier: | NCT01372189 History of Changes |
| Other Study ID Numbers: | 2011SDU-QILU-G01 |
| Study First Received: | January 18, 2011 |
| Last Updated: | January 30, 2012 |
| Health Authority: | China: Ministry of Health |
Keywords provided by Shandong University:
|
molecular imaging epidermal growth factor receptor colorectal neoplasia confocal laser endomicroscopy |
Additional relevant MeSH terms:
|
Adenoma Neoplasms Colorectal Neoplasms Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type Intestinal Neoplasms Gastrointestinal Neoplasms Digestive System Neoplasms Neoplasms by Site |
Digestive System Diseases Gastrointestinal Diseases Colonic Diseases Intestinal Diseases Rectal Diseases Mitogens Mitosis Modulators Molecular Mechanisms of Pharmacological Action Pharmacologic Actions |
ClinicalTrials.gov processed this record on June 18, 2013